Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Judge Gorsuch Could Be Pharma Ally In FDA Disputes

Feb 20 2017

• By Brenda Sandburg

US-Supreme-Court_V1_1200

Related Content

Adverse Events Disclosures May Increase After Supreme Court Ruling Against Matrixx, But "Total Mix" Matters

Mar 22 2011

‘Intended Use’ Rule: Industry Urges US FDA To Revoke ‘Totality Of Evidence’ Standard

Feb 13 2017

Supreme Court Lets Vioxx Securities Suit Against Merck Stand

Apr 27 2010

Legal Briefs: Courts On Exclusivity; Namenda ‘Hard Switch’ Deemed Coercive; Acorda Fights Bass Patent Petition

Jun 01 2015

Securities Fraud Class Action Suits Could Grow After Amgen’s Supreme Court Loss

Feb 28 2013

Related Companies

Amarin Corp plc

Merck & Co., Inc.

Amgen, Inc.

Additional Topics

Policy Legal Issues FDA BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window